. ppd headquarters in downtown wilmington nc type private industry contract research organizations pharmaceutical biotechnology founded 1985 headquarters wilmington north carolina united states key people see principal officers page of the ppd website 1 products contract clinical research for pharmaceutical biotechnology medical device academic and government organizations ; services include discovery development lifecycle management and laboratory services . number of employees 16 000 2016 website www.ppdi.com pharmaceutical product development llc ppd is a global contract research organization cro providing discovery development and post approval services as well as compound partnering programs . the company s clients and partners include pharmaceutical biotechnology medical device academic and government organizations . ppd is mainly known for conducting drug development for its clients it also invests in developing new products through its compound partnering program . contents 1 history 2 location 3 operations 4 clinical development services 5 laboratory services 6 discovery sciences compound partnering 7 references 8 external links history edit ppd was founded by fred eshelman pharm.d . as a one person consulting firm in 1985 . the following year he expanded the company s scope to include development services and relocated operations from maryland to north carolina . july 1985 fred eshelman pharm.d . founds ppd as a one person consulting firm based in his home in maryland . 1986 eshelman expands the company and relocates operations to wilmington north carolina . jan. 1989 the company incorporates in north carolina . jan. 1996 ppd issues its initial public stock offering and begins trading on the nasdaq national market system under the symbol ppdi . oct. 2005 ppd s board of directors adopts an annual cash dividend policy . july 2009 the company promotes eshelman to executive chairman and names david grange chief executive officer . jan. 2010 the company commemorates the 25th anniversary of its founding . june 2010 ppd spins off its compound partnering division as a new and independent publicly traded company furiex pharmaceuticals . may 2011 david grange retires as chief executive officer of ppd . 2 sept. 2011 ppd s board of directors names raymond hill as ppd s new chief executive officer . dec. 2011 the company is acquired by affiliates of the carlyle group and affiliates of hellman & friedman in an all cash transaction valued at approximately 3.9 billion . 3 may 2012 ppd s board of directors names david simmons as chairman and ceo . 4 location edit ppd maintains its worldwide headquarters in wilmington n.c. the company has more than 16 000 employees and offices in 46 countries . operations edit ppd provides drug discovery development lifecycle management and laboratory services . ppd has a 300 bed healthy volunteer phase i clinic and a dental research clinic in austin texas . clinical development services edit ppd provides product development and post approval services for biopharmaceuticals and devices as well as full service phase ii iiib clinical studies for multinational regulatory submissions . ppd also offers clinical data management and information solutions including consulting and proprietary software tools to speed collection analysis and reporting of clinical trial data . laboratory services edit ppd provides bioanalytical cgmp product analysis central laboratory and vaccines and biologics lab services . discovery sciences compound partnering edit the discovery sciences segment offers biomarker discovery services nonclinical development and preclinical services . through its compound partnering program it also seeks to in license early stage compounds take them through proof of concept and out license them to its partners for late clinical testing and commercialization . ppd shares in the risks and rewards of bringing a drug to market gaining revenues generated by licensing fees milestone payments and commercial royalties . the company s post approval services include epidemiology risk management and outcomes research ; late stage trials ; medical information ; product safety ; registries and observational studies . references edit principal officers . retrieved 2 march 2015 . william faulkner may 20 2011 . david grange retires as ceo of ppd . wilmington starnews . peter lattman october 3 2011 . buyout firms to buy drug research company for 3.9 billion . new york times . william faulkner may 23 2012 . ppd names new ceo . wilmington starnews . external links edit ppd corporate website retrieved from https en.wikipedia.org w index.php title pharmaceutical product development & oldid 729525707 categories pharmaceutical companies of the united statescontract research organizationscompanies based in wilmington north carolinacompanies formerly listed on nasdaq navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages fran ais edit links this page was last modified on 12 july 2016 at 20 13 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view